GlassScriptPhysician profile
Omer Alsheikh
NPI 1407344088
$3,456.15
in general payments reported to CMS, 2019-2025
24 companies · $1,641 in 2025
The $1,641 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $718 · 2024: $1,098 · 2025: $1,641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,037 · Education: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,036.92 |
| Education | $419.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $594.25 | 2024-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $308.74 | 2023-2025 | Lifevest |
| Boston Scientific Corporation | $294.20 | 2024-2025 | Emblem Mri S-Icd, Watchman Flx, General - Balloon Catheters |
| Abbott Laboratories | $290.11 | 2023-2025 | Ensite, Optis, Xience Skypoint |
| Penumbra, INC. | $244.08 | 2023-2025 | Indigo System |
| Chiesi USA, INC. | $241.95 | 2023-2025 | Kengreal, Cleviprex |
| Shockwave Medical, INC | $207.73 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $188.46 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Teleflex LLC | $153.95 | 2023-2025 | Turnpike |
| Janssen Pharmaceuticals, INC | $153.83 | 2023-2024 | Xarelto |
| Inari Medical, INC. | $144.01 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $135.43 | 2025 | Repatha |
| Merck Sharp & Dohme LLC | $84.27 | 2024 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $69.91 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $59.51 | 2024-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.40 | 2023-2024 | Jardiance |
| Pfizer INC. | $49.93 | 2024 | |
| Cordis US Corp. | $48.69 | 2023-2024 | Mynxgrip, Precise Pro Rx |
| Biosense Webster, INC. | $33.46 | 2024 | Carto 3 |
| Genzyme Corporation | $28.35 | 2023 | |
| Terumo Medical Corporation | $25.45 | 2023 | Angio-Seal |
| Impulse Dynamics (USA) INC. | $19.19 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $16.33 | 2023 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $13.92 | 2024 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omer Alsheikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.